Life Science Big News Roundup: Lexaria Bioscience Announces Beverage License Agreement; NanoSphere Received Notice of Allowance for a Patent for its Breakthrough Nanoparticle Encapsulations of NSAIDs Life Science Investing News
Lexaria Bioscience Announces Beverage License Agreement with California-Based Cannabis Company Cannabis Investing News
Asterion Signs Land Purchase Agreement for 75 Hectares of Land for its Queensland Medicinal Cannabis Facility Cannabis Investing News
Relevium Technologies: Global Brands for the Nutraceutical and Wellness Markets Pharmaceutical Investing
La Jolla Pharmaceutical Company Announces U.S. FDA’s Grant of Breakthrough Therapy Designation for LJPC-0118 Pharmaceutical Investing
NanoSphere Health Sciences Has Received Notice of Allowance for a Patent for its Breakthrough Nanoparticle Encapsulations of NSAIDs Biotech Investing
BriaCell Announces Publication at American Society of Clinical Oncology (ASCO) Meeting and Presentation at Precision Breast Cancer Summit in Boston Biotech Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
